OptimizeRx Corporation

NasdaqCM:OPRX 株式レポート

時価総額：US$81.4m

OptimizeRx マネジメント

マネジメント 基準チェック /24

OptimizeRxの CEO はWill Febboで、 Feb2016年に任命され、 の在任期間は 8.75年です。 の年間総報酬は$ 2.79Mで、 16.1%給与と83.9%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の2.75%を直接所有しており、その価値は$ 2.24M 。経営陣と取締役会の平均在任期間はそれぞれ3.5年と6.7年です。

主要情報

Will Febbo

最高経営責任者

US$2.8m

報酬総額

CEO給与比率16.1%
CEO在任期間8.8yrs
CEOの所有権2.7%
経営陣の平均在職期間3.5yrs
取締役会の平均在任期間6.7yrs

経営陣の近況

Recent updates

Does OptimizeRx (NASDAQ:OPRX) Have A Healthy Balance Sheet?

Nov 16
Does OptimizeRx (NASDAQ:OPRX) Have A Healthy Balance Sheet?

OptimizeRx (NASDAQ:OPRX) Is Carrying A Fair Bit Of Debt

Jul 30
OptimizeRx (NASDAQ:OPRX) Is Carrying A Fair Bit Of Debt

OptimizeRx Corporation's (NASDAQ:OPRX) 36% Jump Shows Its Popularity With Investors

Jan 09
OptimizeRx Corporation's (NASDAQ:OPRX) 36% Jump Shows Its Popularity With Investors

Analyst Forecasts Just Became More Bearish On OptimizeRx Corporation (NASDAQ:OPRX)

Aug 24
Analyst Forecasts Just Became More Bearish On OptimizeRx Corporation (NASDAQ:OPRX)

OptimizeRx Corporation (NASDAQ:OPRX) Shares May Have Slumped 38% But Getting In Cheap Is Still Unlikely

Aug 16
OptimizeRx Corporation (NASDAQ:OPRX) Shares May Have Slumped 38% But Getting In Cheap Is Still Unlikely

Is Now An Opportune Moment To Examine OptimizeRx Corporation (NASDAQ:OPRX)?

May 31
Is Now An Opportune Moment To Examine OptimizeRx Corporation (NASDAQ:OPRX)?

OptimizeRx: A Top Candidate For My Speculative 'Bio Boom' Portfolio

Oct 12

Is Now The Time To Look At Buying OptimizeRx Corporation (NASDAQ:OPRX)?

Sep 23
Is Now The Time To Look At Buying OptimizeRx Corporation (NASDAQ:OPRX)?

OptimizeRx extends reach with Cooler Screens Partnership

Jul 26

OptimizeRx: A Small-Cap Digital Health Technology Gem With Near-Term Inflection In Profitability

Jun 27

The Strong Earnings Posted By OptimizeRx (NASDAQ:OPRX) Are A Good Indication Of The Strength Of The Business

Nov 16
The Strong Earnings Posted By OptimizeRx (NASDAQ:OPRX) Are A Good Indication Of The Strength Of The Business

Why We Think OptimizeRx Corporation's (NASDAQ:OPRX) CEO Compensation Is Not Excessive At All

Aug 13
Why We Think OptimizeRx Corporation's (NASDAQ:OPRX) CEO Compensation Is Not Excessive At All

A Look At The Fair Value Of OptimizeRx Corporation (NASDAQ:OPRX)

Jul 15
A Look At The Fair Value Of OptimizeRx Corporation (NASDAQ:OPRX)

Here's Why We're Not At All Concerned With OptimizeRx's (NASDAQ:OPRX) Cash Burn Situation

Jun 24
Here's Why We're Not At All Concerned With OptimizeRx's (NASDAQ:OPRX) Cash Burn Situation

Investors Will Want OptimizeRx's (NASDAQ:OPRX) Growth In ROCE To Persist

May 10
Investors Will Want OptimizeRx's (NASDAQ:OPRX) Growth In ROCE To Persist

CEO報酬分析

OptimizeRx の収益と比較して、Will Febbo の報酬はどのように変化したか？
日付総報酬給与会社業績
Sep 30 2024n/an/a

-US$24m

Jun 30 2024n/an/a

-US$18m

Mar 31 2024n/an/a

-US$18m

Dec 31 2023US$3mUS$450k

-US$18m

Sep 30 2023n/an/a

-US$14m

Jun 30 2023n/an/a

-US$14m

Mar 31 2023n/an/a

-US$14m

Dec 31 2022US$694kUS$450k

-US$11m

Sep 30 2022n/an/a

-US$10m

Jun 30 2022n/an/a

-US$7m

Mar 31 2022n/an/a

-US$3m

Dec 31 2021US$15mUS$410k

US$378k

Sep 30 2021n/an/a

US$1m

Jun 30 2021n/an/a

US$789k

Mar 31 2021n/an/a

-US$641k

Dec 31 2020US$1mUS$350k

-US$2m

Sep 30 2020n/an/a

-US$6m

Jun 30 2020n/an/a

-US$7m

Mar 31 2020n/an/a

-US$5m

Dec 31 2019US$834kUS$300k

-US$3m

Sep 30 2019n/an/a

-US$1m

Jun 30 2019n/an/a

US$548k

Mar 31 2019n/an/a

US$422k

Dec 31 2018US$923kUS$275k

US$226k

Sep 30 2018n/an/a

US$99k

Jun 30 2018n/an/a

-US$769k

Mar 31 2018n/an/a

-US$1m

Dec 31 2017US$422kUS$250k

-US$2m

報酬と市場: Willの 総報酬 ($USD 2.79M ) は、 US市場 ($USD 652.28K ) の同規模の企業の平均を上回っています。

報酬と収益: Willの報酬は増加しましたが、会社は利益を上げていません。

CEO（最高経営責任者

Will Febbo (55 yo)

8.8yrs

在職期間

US$2,789,528

報酬

Mr. William J. Febbo, also known as Will, is a Director at LifeMD, Inc. since June 2023. He served as an Independent Director at Augmedix, Inc. since March 28, 2022 until October 02, 2024. He served as an...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
William Febbo
CEO & Director8.8yrsUS$2.79m2.75%
$ 2.2m
Stephen Silvestro
President1.8yrsUS$970.36k0.42%
$ 339.8k
Edward Stelmakh
CFO & COO3.1yrsUS$929.73k0.14%
$ 116.2k
Andrew D'Silva
Senior Vice President of Corporate Finance3.2yrsデータなしデータなし
Marion Odence-Ford
General Counsel & Chief Compliance Officer3.8yrsUS$2.51m0.11%
$ 89.2k
Maira Alejandra
Media Relations Managerno dataデータなしデータなし
Sheryl Kearney
Human Resources Manager4.9yrsデータなしデータなし
Terence Hamilton
Senior Vice President of Pharma4.7yrsUS$511.63kデータなし
Doug Besch
Chief Product Officer2.1yrsデータなし0.034%
$ 27.4k
Theresa Greco
Chief Commercial Officer1.1yrsデータなし0.12%
$ 101.7k
Brian McCarthy
Chief Revenue Officerno dataデータなしデータなし
Heather Favazza
Controller6.1yrsデータなしデータなし

3.5yrs

平均在職期間

56.5yo

平均年齢

経験豊富な経営陣: OPRXの経営陣は 経験豊富 であると考えられます ( 3.5年の平均在職年数)。

取締役

名称ポジション在職期間報酬所有権
William Febbo
CEO & Director8.5yrsUS$2.79m2.75%
$ 2.2m
Patrick Spangler
Independent Director6.7yrsUS$215.01k0.17%
$ 142.2k
Catherine Klema
Independent Directorless than a yearデータなしデータなし
Gregory Wasson
Independent Director4.3yrsUS$195.01k0.18%
$ 150.4k
Ellen Vos
Independent Chairperson of the Board9.2yrsUS$208.01k0.27%
$ 218.7k
Jack Pinney
Head of Medical Advisory Board6.7yrsUS$112.91kデータなし
James Lang
Independent Director7.8yrsUS$204.01k0.30%
$ 242.0k

6.7yrs

平均在職期間

66yo

平均年齢

経験豊富なボード: OPRXの 取締役会 は 経験豊富 であると考えられます ( 6.7年の平均在任期間)。